Target Price Playground
DRMA
$0.58
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on DRMA? Launch with your exact active legs & +-12.0% target.
Forward Projection
If price hits $1 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Bearish. Max profit if underlying crashes, capped loss.
๐ฏ Target
1-Click Institutional Target Anchors:
59d from today
โ๏ธ Legs
LONG PUT ยท $1 ยท Jan '27
Qty 1 ยท Premium $0.01 ยท ฮ -0.13
P&L at Expiry
Stock (100 sh)
Long Put
Now
Target
๐ก Stock vs Options at Target
If DRMA hits $1 by Jan 15: the long put returns $-1 (-100.6%) on $1 risked, vs $-7 (-11.4%) for 100 shares on $58. Options give 8.8ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (59 days out). P&L shown is the value at expiry if DRMA is at $1.
๐ Projected Return
P&L if DRMA hits $1 by Jan 15
$-1
-100.6% on $1 risked
Max Profit
+$49
If stock โ $0
Max Loss
โ$1
Premium paid
Break-even
$0.49
-14.11% from spot
Prob. of Profit at Expiry (PoP)
14.4%
Below breakeven ($0.49)
ยท Touch Target: 42%
Net ฮ / ฮ / V
-13.09 / -0.01 / 0.05
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| DRMA Price | Today | +3d (Nov 20) | +7d (Nov 24) | Dec 6 | Dec 26 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $0 (-20.7%) | +$4 | +$4 | +$4 | +$4 | +$3 | +$3 |
| $0 (-15.5%) | +$3 | +$3 | +$2 | +$2 | +$1 | +$0 |
| $1 (-12.1%) โ target | +$2 | +$2 | +$1 | +$1 | +$0 | -$1 |
| $1 (-10.3%) โ target | +$1 | +$1 | +$1 | +$1 | -$0 | -$1 |
| $1 (-5.2%) | +$0 | +$0 | +$0 | -$0 | -$1 | -$1 |
| $1 (-1.7%) | +$0 | +$0 | -$0 | -$0 | -$1 | -$1 |
| $1 (0%) โ spot | +$0 | -$0 | -$0 | -$0 | -$1 | -$1 |
| $1 (+1.7%) | -$0 | -$0 | -$0 | -$0 | -$1 | -$1 |
| $1 (+5.2%) | -$0 | -$0 | -$0 | -$1 | -$1 | -$1 |
| $1 (+10.3%) | -$0 | -$0 | -$0 | -$1 | -$1 | -$1 |
| $1 (+15.5%) | -$0 | -$0 | -$1 | -$1 | -$1 | -$1 |
| $1 (+20.7%) | -$0 | -$1 | -$1 | -$1 | -$1 | -$1 |
Uses DRMA's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.